GAMB vs GHG

The deterministic health profile is critically weak, highlighted by a Piotroski F-Score of 2/9 and a technical trend score of 0/100. While the company maintains impressive gross margins (90.78%) and strong revenue growth (31%), these are overshadowed by a severe collapse in earnings and a 70.6% one-year price decline. The stock is currently trading near its 52-week low, and despite a 'strong buy' analyst consensus, the recent quarterly earnings miss (-588.9% surprise) suggests a fundamental disconnect between analyst expectations and operational reality.

GHG presents a classic 'value trap' profile, characterized by a strong Piotroski F-Score of 7/9 and extreme undervaluation relative to its Graham Number ($3.80) and Intrinsic Value ($1.82). While the company maintains healthy liquidity (Current Ratio 1.64) and positive margins, it is plagued by negative revenue growth (-15% YoY) and a catastrophic 5-year price decline of 88.8%. The deterministic health scores suggest operational stability, but the market is pricing in a structural decline in the business model, as evidenced by the 0/100 technical trend.